Page 1

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement , make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement . 国药 集团 SINOPHARM 國藥 控股 股份有限公司 SINOPHARM GROUP CO . LTD . * ( A joint stock limited company incorporated in the People's Republic of China with limited liability and carrying on business in Hong Kong as 國 控 股份有限公司 ) ( Stock Code : 01099 ) ANNOUNCEMENT Pursuant to the rules of the National Association of Financial Market Institutional Investors and the Shanghai Stock Exchange , Sinopharm Group Co. Ltd. ( the “ Company ” ) is required to publish the quarterly financial information of the Company and its subsidiaries ( the “ Group ” ) which consists of consolidated balance sheet , consolidated income statement and consolidated cash flow statement of the Group , and to publish the quarterly financial information of the Company which consists of balance sheet , income statement and cash flow statement of the Company . This announcement is made pursuant to Part XIVA of the Securities and Futures Ordinance ( Chapter 571 of the Laws of Hong Kong ) and Rule 13.09 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited . The board of directors of the Company is pleased to announce the unaudited financial information of the Group and of the Company for the nine months ended 30 September 2021 prepared in accordance with the PRC GAAP . - 1 -